Treatment of Refractory Immune Thrombocytopenia
Latest Information Update: 29 Jan 2025
Price :
$35 *
At a glance
- Drugs BCMA CD19 cCAR T-cell therapy-iCell Gene Therapeutics (Primary)
- Indications Thrombocytopenia
- Focus Adverse reactions
- Sponsors iCell Gene Therapeutics
- 29 Jan 2025 New trial record